Exclusive

Publication

Byline

Bristol Myers Squibb names Singapore as new Pan Asia Hub

Singapore, July 8 -- Bristol Myers Squibb (BMS), a global biopharmaceutical leader, recently celebrated its 60th anniversary in Singapore by recognising it as a new Pan Asia Cluster (PAC) hub for the ... Read More


Australia's breakthrough in search for Motor Neurone Disease treatment

Singapore, July 8 -- Australia-based University of Queensland (UQ) researchers have developed a drug that activates a hard-to-target immune receptor - a breakthrough which could lead to new treatments... Read More


Japan's Tanabe sells Pharma Factory to Towa Pharmaceutical

Singapore, July 8 -- Japan-based Tanabe Pharma has decided to transfer the domestic manufacturing and marketing approvals, manufacturing and marketing rights, and related assets for 17 products across... Read More


Taiwan's Lotus Pharma commences distribution of Uro-Vaxom(R) in South Korea

Singapore, July 7 -- Lotus Pharmaceutical, a global pharmaceutical company headquartered in Taiwan, has announced that its wholly owned subsidiary Alvogen Korea has commenced distribution of Uro-Vaxom... Read More


Orion and Shilpa Medicare expand partnership to develop Nivolumab Biosimilar for Europe

Singapore, July 7 -- Shilpa Medicare has announced that its wholly owned subsidiary, Shilpa Biologicals has entered into a co-development and supply agreement with Orion Corporation, a globally operat... Read More


Korea's Neurophet to supply neurodegenerative brain imaging analysis software to Raffles Medical in Singapore

Singapore, July 7 -- South Korea-based Neurophet, an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, has signed a supply agreement with Raffles Medical for i... Read More


Sanyou Bio and Baiyunshan Xihe join forces to advance innovative radiopharma and radiodiagnostics

Singapore, July 6 -- China-based Sanyou Biopharmaceutical and Guangzhou Baiyunshan Xihe Health Pharmaceutical have jointly announced the official signing of a strategic cooperation agreement. This par... Read More


UCL and Eisai renew partnership to accelerate treatments for neurodegenerative diseases

Singapore, July 6 -- University College London (UCL) and Japanese pharma firm Eisai have signed a new agreement to extend their long-standing collaboration in drug discovery and development for five m... Read More


Matica Bio, VaxDome partner on antigen-agnostic antiviral-vaccine hybrids

Singapore, July 6 -- Matica Biotechnology has entered a partnership with VaxDome to support development of antigen-agnostic antiviral-vaccine hybrid candidates. Under the agreement, Matica Bio will p... Read More


Ascletis submits US IND applications for once-monthly obesity candidates

Singapore, July 6 -- Ascletis Pharma has submitted two Investigational New Drug applications to the U.S. FDA for obesity treatment candidates ASC36 and ASC36_35 FDC. ASC36 is a next-generation peptid... Read More